Advances in Urology / 2017 / Article / Tab 3

Clinical Study

The Persistence of Silodosin Monotherapy and the Reasons for Withdrawal from Treatment of Previously Untreated Japanese Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia

Table 3

Changes of mean IPSS in patients who continued the silodosin treatment ().

Parameters0 mos.3 mos.6 mos.12 mos.18 mos.24 mos.30 mos.36 mos.42 mos.48 mos.

Total score15.211.6
(SD)(6.9)(7.5)(7.0)(7.3)(7.0)(7.5)(6.9)(8.2)(8.2)(7.8)
Storage subscore7.15.4
(SD)(3.5)(3.0)(3.3)(3.3)(3.0)(3.1)(3.6)(3.9)(3.6)(3.8)
Voiding subscore6.64.05.14.3
(SD)(4.1)(4.0)(3.8)(4.0)(3.9)(3.9)(3.7)(4.2)(4.1)(3.9)
QOL index4.8
(SD)(0.9)(1.5)(1.5)(1.6)(1.6)(1.7)(1.4)(1.7)(1.6)(1.6)

, , and versus baseline, the paired Student’s -test with Bonferroni correction.